Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Isamu TachibanaAndre AlabdYan TongAlex PirooziMohammad MahmoudSean Q KernTimothy A MastersonNabil AdraRichard S FosterNasser H HannaLawrence H EinhornClint CaryPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
CS II seminoma can be treated with surgery to avoid rigors of chemotherapy or radiotherapy. Patients with delayed development of CS II disease (> 12 months) had the best surgical results. Patients may present with borderline CS II disease, and careful surveillance may avoid overtreatment. Further study on patient selection and extent of dissection remains uncertain and warrants further investigation.
Keyphrases
- minimally invasive
- end stage renal disease
- coronary artery bypass
- newly diagnosed
- public health
- chronic kidney disease
- ejection fraction
- early stage
- prostate cancer
- peritoneal dialysis
- squamous cell carcinoma
- atrial fibrillation
- percutaneous coronary intervention
- acute coronary syndrome
- radical prostatectomy
- radiation induced
- patient reported outcomes
- patient reported